Abstract submission is closed.

Abstract submission deadline was Friday, June 9, 2017, midnight Central European Time (CET)
Notification of Abstract Status
All individuals listed as ABSTRACT PRESENTERS will be notified of acceptance or rejection by email. Due to the high number of submitted abstracts, we are still in the reviewing process. Reviewing should be finalized in the last week of July, and notifications will be sent on July 31 to the email address provided at the time of abstract submission. If an abstract is not selected for presentation, the presenter may request a full refund of the registration fee by contacting office@cimt.eu.

Presentation and Publication
Abstracts selected for presentation during the conference will be printed in the Conference Proceedings from submitted material. Every effort will be made to reproduce the content of the abstracts as submitted, except in certain circumstances where changes may be made to comply with the conference style guide. Full abstracts will be posted on this website and on the conference app one week prior to the conference. Poster boards dimensions will be provided in email correspondence to the ABSTRACT PRESENTERS.  The organizers will provide poster numbers and pushpins.
From the accepted posters, a vey small number of highly rated abstract authors will also be invited to deliver short oral presentations of their work during the general sessions.  All abstracts will be considered.  Instructions will be sent to the ABSTRACT PRESENTERS with the date, time, and format for these presentations.
Conference Registration
All abstract authors must register for the conference prior to the submission of an abstract. If an abstract is not accepted, the presenter may request a full refund of the registration fee.
Request for Withdrawal
Once an abstract has been submitted, it may be withdrawn only by written request from the ABSTRACT PRESENTER. The request may be sent by email to info@cancerimmunotherapyconference.org and must be received at least 30 days prior to the start of the conference.
 
Abstract submissions were only accepted through the online abstract submission platform. Paper abstracts were not accepted. Only those abstracts that have been reviewed and selected by the Scientific Planning Committee may be presented. Please be sure to carefully check your abstract for content errors, spelling, names, etc. before submitting. The organizers do not proofread or correct spelling, typographical, grammatical, or scientific errors, nor can changes be made once the abstract is submitted. For technical questions, please contact the abstract submission help desk icic2017@abstractserver.com.
If you have policy related questions, please contact the conference organizers at
info@cancerimmunotherapyconference.org or at office@cimt.eu
Abstract Categories
  • Neoantigens and Cancer Mutations
  • Cancer Vaccines and Targets
  • Oncolytic Viruses
  • Adoptive Cell Therapy
  • Checkpoint Blockade Therapy
  • Combination Therapies
  • New Agents and Their Mode of Action
  • Clinical Trials of Cancer Immunotherapies
  • Immunomonitoring and Biomarkers
  • Tumor Microenvironment and Its Modulation
  • Cancer-Mediated Immunosuppression
  • Microbiota